Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 14/20 | 0.48 |
| ▸ | STAT3 | P40763 | 4/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12909328 | 0.89 | SELE (0.54) | SELE | |
| SCHEMBL12257338 | 0.81 | SELE (0.62) | SELESTAT3 | |
| SCHEMBL12902990 | 0.81 | SELE (0.51) | SELE | |
| SCHEMBL14096760 | 0.80 | SELE (0.47) | SELESTAT3AMY1A | |
| SCHEMBL11962146 | 0.79 | SELE (0.66) | SELESTAT3 | |
| SCHEMBL9613573 | 0.78 | SELE (0.64) | SELESTAT3 | |
| SCHEMBL12233120 | 0.78 | STAT3 (0.44) | SELESTAT3 | |
| SCHEMBL12902995 | 0.76 | SELE (0.51) | SELE | |
| SCHEMBL12902994 | 0.76 | SELE (0.49) | SELE | |
| SCHEMBL11962142 | 0.74 | SELP (0.57) | SELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9486497-B2 | Treatment of immunocompromised conditions | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-11-08 | — | — | US | disclosed |
| US-20110002881-A1 | TREATMENT AND PROPHYLAXIS | MATER MEDICAL RESEARCH INSTITUTE (AU) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110002881-A1 | TREATMENT AND PROPHYLAXIS | SELP, SELE, SELPLG | SELE 2/4885STAT3 1643/4885AMY1A 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.